Portfolio Design Labs’s Regeneron Pharmaceuticals REGN Stock Holding History

Portfolio Design Labs’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,043	Closed	-$548K	–	224
2025 Q2	$548K	Buy	1,043 +319	+44%	+$178K	0.11%	105
2025 Q1	$459K	Buy	724 +223	+45%	+$153K	0.09%	126
2024 Q4	$357K	Buy	501 +199	+66%	+$167K	0.07%	135
2024 Q3	$317K	Buy	302 +26	+9%	+$28.9K	0.09%	117
2024 Q2	$290K	Sell	276 -2	-0.7%	-$1.94K	0.09%	89
2024 Q1	$268K	Sell	278 -242	-47%	-$230K	0.09%	101
2023 Q4	$457K	Buy	+520	New	+$428K	0.17%	90

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Portfolio Design Labs's REGN Position: Q3 2025 in Review

Portfolio Design Labs sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 1,043 shares — an estimated $548K sold.

Portfolio Design Labs first reported a position in REGN in Q4 2023 and held it in 7 quarters. The position peaked at $548K in Q2 2025. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

Portfolio Design Labs reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Portfolio Design Labs sold 1,043 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $548K.
Portfolio Design Labs first reported a position in Regeneron Pharmaceuticals in Q4 2023 and held it in 7 quarters.
Portfolio Design Labs's Regeneron Pharmaceuticals position peaked at $548K in Q2 2025.
1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Portfolio Design Labs's 13F filing for Q3 2025, filed 12 Nov 2025.